Home > Healthcare > Pharmaceuticals > Finished Drug Form > Pregnancy Medication Market
Pregnancy Medication Market Size
Pregnancy Medication Market size was valued at over USD 33 billion in 2022 and is poised to witness 13% CAGR from 2023 to 2032.
Rapid development in incidences of pregnancy-associated complications is expected to drive the demand for pregnancy medication. Based on estimates by the World Health Organization, every day, almost 800 women worldwide die due to complications during childbirth. These intricacies are 36 times more prevalent in developing economies than in developed countries. The alarming progress in childbirth-related complications can be attributed to improper dietary habits, physical inactivity, and the rising adoption of a sedentary lifestyle.
Consumption of unhealthy food during pregnancy can increase the risk of developing various long-term irreversible health issues. These may range from high blood pressure, cholesterol, heart diseases, and type 2 diabetes to defective childbirth. The rapid inclination toward maintaining a proper nutritional diet rich in all micro and macronutrients to support the health of the mother and the fetus will create positive growth prospects for the pregnancy medication industry.
| Report Attributes | Details |
|---|---|
| Base Year: | 2022 |
| Market Size in 2022: | 33 Billion (USD) |
| Forecast Period: | 2023 to 2032 |
| Forecast Period 2023 to 2032 CAGR: | 13% |
| 2032 Value Projection: | 112 Billion (USD) |
| Historical Data for: | 2017 to 2022 |
| No. of Pages: | 255 |
| Tables, Charts & Figures: | 261 |
| Segments covered: | Drug Class, Pregnancy Stage, Distribution Channel, and Region |
| Growth Drivers: |
|
| Pitfalls & Challenges: |
|
Pregnancy Medication Market Trends
The intake of other medications and the possible side effects and health risks associated with them may limit the pregnancy medication market value. A significant share of pregnant women consumes over-the-counter drugs for several comorbidities, such as CVDs, which are one of the leading causes of death among pregnant women. These medications may also lead to premature birth, low birth weight, stillbirth, and other complications, which may downsize the market share.
Pregnancy Medication Market Analysis
Pregnancy medication market from nutritional supplements segment garnered revenues worth over USD 16.5 billion in 2022. Nutritional supplements comprising omega-3, vitamins, minerals, folic acid, multivitamins, and others support the development of the placenta and fetus while preventing the risk of neural tube defects. The growing emphasis on maintaining a healthy diet to minimize the prospects of birth defects and improper nutrition in babies will propel the segment size.
The 2nd-trimester segment is expected to exhibit over 13% CAGR from 2023 to 2032. The intake of pregnancy medications and supplements in the 2nd-trimester improves sensory gating and reduces the risk of later attention deficits and psychological disorders. Health complications such as separation of the placenta from the uterus, increased preterm labor, and other risk factors are quite prevalent during the 4th to 6th months of pregnancy. Hence, in light of these complications, the pregnancy medication demand will accelerate throughout the projection period.
Pregnancy medication market from retail pharmacy segment is anticipated to amass nearly 28% business share by 2032. Retail pharmacies are easily accessible to patients and have the availability of a broad range of healthcare products and everyday items. These establishments are equipped with skilled pharmacists offering uniquely tailored personalized advice to patients based on their health issues. Access to high-quality consumer service at affordable prices across these settings will help retail pharmacies emerge as major expansion contributors in the ensuing years.
Europe pregnancy medication market is slated to cross USD 23 billion by 2032. The increasing number of market participants organizing social media campaigns and health initiatives to create awareness about proper health and diet among pregnant women will stimulate the regional market landscape. In addition, the growing incidences of birth defects and congenital anomalies, coupled with the availability of high-quality health supplements, will positively influence the industry dynamics across Europe.
Pregnancy Medication Market Share
Major companies participating in the pregnancy medication industry are
- Alkem Laboratories Limited
- Piramal Enterprises Limited
- F.Hoffman-La Roche Ltd
- Pfizer
- Dr. Reddy’s Laboratories
- Cipla Inc
- Alembic Pharmaceuticals Ltd
- Lupin Limited
- Glenmark Pharmaceuticals Ltd
- Viatris Inc. (Mylan Inc.)
- Amgen Inc.
These players have been adopting brand acquisitions, mergers, and collaboration as part of their key growth strategy.
For instance, in June 2022, Glenmark Pharmaceuticals Ltd. and its U.S. subsidiary announced the acquisition of Wockhardt Ltd.'s generic interpretations of 4 OTC drugs. The move designated the continued expansion of the firm's over-the-counter business in the U.S., comprising vitamins, minerals, and other products.
Impact of COVID-19 Pandemic
The COVID-19 pandemic had a favorable impact on the pregnancy medication industry. This can be credited to the rapid surge in pregnancies during the crisis and the rising awareness about the benefits of nutritional supplements in child growth and development. Based on a poll conducted by United Nations, several countries such as China, Pakistan, and India have witnessed a visible rise in the number of pregnancies during lockdowns, with nearly 13.5 million, 5 million, and 7 million pregnancies registered during the given period. The increasing sales of prenatal supplements to eliminate prospective childbirth complications may further boost the market outlook.
The pregnancy medication market report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD million from 2018 to 2032 for the following segments: Click here to Buy Section of this Report
By Drug Class
- Antianemia
- Antacids
- Antiallergic
- Analgesics
- Antimicrobials
- Hormones
- Laxatives
- Vaccines
- Nutritional Supplements
- Minerals
- Omega 3
- Folic Acid
- Vitamins
- Multivitamins
- Others
- Others
By Pregnancy Stage
- 1st trimester
- 2nd trimester
- 3rd trimester
By Distribution Channel
- Hospital pharmacy
- Retail pharmacy
- Online pharmacy
The above information is provided for the following regions and countries:
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Spain
- Italy
- Others
- Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- Others
- Latin America
- Brazil
- Mexico
- Argentina
- Others
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
Frequently Asked Questions (FAQ) :